What is OSRH's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.01B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for OSRH?

P/E (TTM) is n/a and 52-week range is $0.07 to $0.91 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s OSRH figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for OSRH?

The company profile lists revenue (TTM) near $1M, net income (TTM) near $-888M, EPS (TTM) near $-0.40 when available from the market-data feed. Figures are informational and may lag live markets.

Where is OSR Holdings Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Bellevue, Washington, US, 35.1M shares outstanding, ISIN US68840D1028 when available from company profile and filing metadata.

OSR Holdings Inc

$OSRH

Health Care · Biotechnology

Run Scenarios

$0.21

-2.33%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

OSR Holdings, Inc. operates as a global healthcare company. The company is headquartered in Bellevue, Washington and currently employs 22 full-time employees. The company went IPO on 2023-02-10. Through its subsidiaries, it is engaged in immuno-oncology, regenerative biologics, and medical device technologies. Its operating businesses include developing oral immunotherapies for the treatment of cancer, developing design-augmented (DA) biologics for age-related and other degenerative diseases and neurovascular intervention medical devices and systems distribution in Korea. Its subsidiaries include VAXIMM AG (Vaximm); RMC Co., Ltd. (RMC); Darnatein Co., Ltd. (Darnatein), and Woori IO Co., Ltd. (Woori IO). Vaximm is developing oral immunotherapies for the treatment of cancer and immunological disorders. RMC is a Korea-based neurovascular intervention medical device and systems distribution company. Darnatein is developing DA biologics for age-related and other degenerative diseases. Woori IO is a South Korea-based medical device company.

Employees

Website

osr-holdings.com/

IPO

2023-02-10

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)